---
title: Gentian Diagnostics ASA – conversion to public limited liability company registered
description: Gentian Diagnostics ASA – conversion to public limited liability company registered
---

Moss, 7 May 2021

Reference is made to the stock exchange announcement made on 4 May 2021 by Gentian Diagnostics AS (the "Company") regarding the annual general meeting held the same date.

The resolutions made by the general meeting, inter alia amendments to the Company's articles of association, including the conversion of the Company into a public limited liability company and change of company name have now been registered with the Norwegian Register of Business Enterprises. The new name of the Company is Gentian Diagnostics ASA.

 

**For further information, please contact:**   
Hilja Ibert CEO, Gentian Diagnostics   
E-mail: [hilja.ibert@gentian.no](mailto:hilja.ibert@gentian.no)    
Cell Phone: +47 919 05 242

Njaal Kind CFO, Gentian Diagnostics   
E-mail: [njaal.kind@gentian.no ](mailto:njaal.kind@gentian.no)  
Cell Phone. +47 919 06 525

### You may also read

[Jul 02, 2026 - Ole Sørlie](https://www.gentian.com/investor-relations-stock-information/investors-news/gentian-diagnostics-asa-conversion-to-public-limited-liability-company-registered#)

##### [Gentian Diagnostics: Invitation to presentation of second quarter results](https://www.gentian.com/investor-relations-stock-information/investors-news/gentian-diagnostics-invitation-to-presentation-of-second-quarter-results-1)

Gentian Diagnostics ASA will present its second quarter 2026 results on 9 July 2026 at 09.00 CEST. The..

[Read more](https://www.gentian.com/investor-relations-stock-information/investors-news/gentian-diagnostics-invitation-to-presentation-of-second-quarter-results-1)

[Jun 24, 2026 - Ole Sørlie](https://www.gentian.com/investor-relations-stock-information/investors-news/gentian-diagnostics-asa-conversion-to-public-limited-liability-company-registered#)

##### [ESSANGE REAGENTS AND GENTIAN DIAGNOSTICS ANNOUNCE COLLABORATION AGREEMENT](https://www.gentian.com/investor-relations-stock-information/investors-news/essange-reagents-and-gentian-diagnostics-announce-collaboration-agreement)

Amsterdam / Moss, 24 June 2026 ESSANGE REAGENTS AND GENTIAN DIAGNOSTICS ANNOUNCE COLLABORATION AGREEMENT..

[Read more](https://www.gentian.com/investor-relations-stock-information/investors-news/essange-reagents-and-gentian-diagnostics-announce-collaboration-agreement)

[May 29, 2026 - Ole Sørlie](https://www.gentian.com/investor-relations-stock-information/investors-news/gentian-diagnostics-asa-conversion-to-public-limited-liability-company-registered#)

##### [Mandatory notification of trade](https://www.gentian.com/investor-relations-stock-information/investors-news/mandatory-notification-of-trade-1780055230560)

Moss, 29 May 2026 Gentian Diagnostics ASA ("Gentian") has today been notified that the following transaction..

[Read more](https://www.gentian.com/investor-relations-stock-information/investors-news/mandatory-notification-of-trade-1780055230560)